MRT-2359

• Description :

  MRT-2359 is a potent and orally available GSPT1 reducer with antitumour activity.MRT-2359 inhibits the growth of drug-resistant non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) cells.MRT-2359 exhibits preferential activity in MYC-driven cell lines.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  495.38

• Molecular Formula :

  C22H17F4N3O6

• Notes :

  Research use only, not for human use.

• Receptor :

  Others

• CAS Number :

  2803881-11-8